Ultragenyx Pharmaceutical Inc. 4

CFO Howard Horn sold 4,698 shares of Ultragenyx Pharmaceutical Inc. common stock at $33.13 per share and now holds 100,991 shares directly.

On July 1, 2026, Ultragenyx Pharmaceutical Inc. Chief Financial Officer Howard Horn sold 4,698 shares of the company’s common stock at an average price of $33.13 per share, for proceeds of approximately $155,609, leaving him with direct ownership of 100,991 shares, which continue to include previously reported RSU-based holdings subject to vesting conditions.

Filing Facts

CIK

1515673

Ticker

RARE

Form

4

Source Type

sec

Accession

0001193125-26-296128

Alert Tier

6